Pharmaceutical Analysis & Statistics, December 2014

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Publishers

  • All
    • Global Data

All regions

You might be interested in: Therapeutics, Drug, Cancer, more »

1-30 of about 6 200 reports

Purchase Reports From Reputable Market Research Publishers

PharmaPoint: HER2-Positive Breast Cancer - Global Drug Forecast and Market Analysis to 2023

PharmaPoint: HER2-Positive Breast Cancer - Global Drug Forecast and Market Analysis to 2023

  • $ 10 995
  • Industry report
  • September 2014
  • by Global Data

PharmaPoint: HER2-Positive Breast Cancer - Global Drug Forecast and Market Analysis to 2023 Summary HER2-positive breast cancer is the second most common cancer in the world and the most common cance ...

  • Industries : Pathology
  • Countries : World
PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update

PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update

  • $ 10 995
  • Industry report
  • September 2014
  • by Global Data

PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update Summary During the forecast period from 2012-2022, the growth of the UC market will be driven largely ...

  • Industries : Drug and Medication
  • Countries : World
OpportunityAnalyzer: Allergic Rhinitis: Allergen-Specific Immunotherapy - Opportunity Analysis and Forecast to 2018

OpportunityAnalyzer: Allergic Rhinitis: Allergen-Specific Immunotherapy - Opportunity Analysis and Forecast to 2018

  • $ 7 995
  • Industry report
  • September 2014
  • by Global Data

OpportunityAnalyzer: Allergic Rhinitis: Allergen-Specific Immunotherapy - Opportunity Analysis and Forecast to 2018 Summary The global specific immunotherapy (SIT) market for allergic rhinitis (AR) is ...

  • Industries : Therapy
  • Countries : Japan, United States
OpportunityAnalyzer: Allergic Conjunctivitis - Opportunity Analysis and Forecasts to 2018

OpportunityAnalyzer: Allergic Conjunctivitis - Opportunity Analysis and Forecasts to 2018

  • $ 7 995
  • Industry report
  • September 2014
  • by Global Data

OpportunityAnalyzer: Allergic Conjunctivitis - Opportunity Analysis and Forecasts to 2018 Summary The allergic conjunctivitis market has remained relatively static over the last few years, due to a limited ...

  • Industries : Therapy
PharmaPoint: HER2-Positive Breast Cancer - 5EU Drug Forecast and Market Analysis to 2023

PharmaPoint: HER2-Positive Breast Cancer - 5EU Drug Forecast and Market Analysis to 2023

  • $ 6 995
  • Industry report
  • September 2014
  • by Global Data

PharmaPoint: HER2-Positive Breast Cancer - 5EU Drug Forecast and Market Analysis to 2023 Summary HER2-positive breast cancer is the second most common cancer in the world and the most common cancer in ...

  • Industries : Pathology
  • Countries : Germany, Spain, Italy, France, United Kingdom, World, Europe
PharmaPoint: HER2-Positive Breast Cancer - US Drug Forecast and Market Analysis to 2023

PharmaPoint: HER2-Positive Breast Cancer - US Drug Forecast and Market Analysis to 2023

  • $ 4 995
  • Industry report
  • September 2014
  • by Global Data

PharmaPoint: HER2-Positive Breast Cancer - US Drug Forecast and Market Analysis to 2023 Summary HER2-positive breast cancer is the second most common cancer in the world and the most common cancer in women ...

  • Industries : Pathology
  • Countries : United States
PharmaPoint: HER2-Positive Breast Cancer - Japan Drug Forecast and Market Analysis to 2023

PharmaPoint: HER2-Positive Breast Cancer - Japan Drug Forecast and Market Analysis to 2023

  • $ 4 995
  • Industry report
  • September 2014
  • by Global Data

PharmaPoint: HER2-Positive Breast Cancer - Japan Drug Forecast and Market Analysis to 2023 Summary HER2-positive breast cancer is the second most common cancer in the world and the most common cancer in ...

  • Industries : Pathology
  • Countries : Japan
PharmaPoint: HER2-Positive Breast Cancer - China Drug Forecast and Market Analysis to 2023

PharmaPoint: HER2-Positive Breast Cancer - China Drug Forecast and Market Analysis to 2023

  • $ 4 995
  • Industry report
  • September 2014
  • by Global Data

PharmaPoint: HER2-Positive Breast Cancer - China Drug Forecast and Market Analysis to 2023 Summary HER2-positive breast cancer is the second most common cancer in the world and the most common cancer in ...

  • Industries : Pathology
  • Countries : China
EpiCast Report: Colorectal Cancer - Epidemiology Forecast to 2023

EpiCast Report: Colorectal Cancer - Epidemiology Forecast to 2023

  • $ 3 995
  • Industry report
  • December 2014
  • by Global Data

EpiCast Report: Colorectal Cancer - Epidemiology Forecast to 2023 Summary Colorectal cancer (CRC) is cancer that starts in the colon or the rectum. CRC has the third highest incidence among all cancers ...

  • Industries : Pathology
  • Countries : World, Spain, Italy, France, Germany, Japan, China
EpiCast Report: Rheumatoid Arthritis - Epidemiology Forecast to 2023

EpiCast Report: Rheumatoid Arthritis - Epidemiology Forecast to 2023

  • $ 3 995
  • Industry report
  • December 2014
  • by Global Data

EpiCast Report: Rheumatoid Arthritis - Epidemiology Forecast to 2023 Summary Rheumatoid arthritis (RA) is an autoimmune disease that causes inflammation of the joints. In RA, the body's immune system attacks ...

  • Industries : Pathology
  • Countries : Japan, India, China, World, Australia, Spain, Italy, France, Germany, United States, United Kingdom, Europe
EpiCast Report: Celiac Disease - Epidemiology Forecast to 2023

EpiCast Report: Celiac Disease - Epidemiology Forecast to 2023

  • $ 3 995
  • Industry report
  • November 2014
  • by Global Data

EpiCast Report: Celiac Disease - Epidemiology Forecast to 2023 Summary Celiac disease is an autoimmune disease that occurs in individuals who consume gluten-containing foods but are intolerant to gluten, ...

  • Industries : Pathology
  • Countries : World, United States, Spain, Italy, France, Germany
EpiCast Report: Type 1 Diabetes - Epidemiology Forecast to 2023

EpiCast Report: Type 1 Diabetes - Epidemiology Forecast to 2023

  • $ 3 995
  • Industry report
  • November 2014
  • by Global Data

EpiCast Report: Type 1 Diabetes - Epidemiology Forecast to 2023 Summary Type 1 diabetes is a type of diabetes that accounts for 10% of all diabetes cases. The condition occurs as a result of the autoimmune ...

  • Industries : Pathology
  • Countries : Canada, Japan, World, United States, Spain, Italy, France, Germany
EpiCast Report: Irritable Bowel Syndrome - Epidemiology Forecast to 2023

EpiCast Report: Irritable Bowel Syndrome - Epidemiology Forecast to 2023

  • $ 3 995
  • Industry report
  • October 2014
  • by Global Data

EpiCast Report: Irritable Bowel Syndrome - Epidemiology Forecast to 2023 Summary Irritable Bowel Syndrome (IBS) is a chronic, relapsing gastrointestinal disorder that is characterized by abdominal discomfort ...

  • Industries : Pathology
  • Countries : Japan, World, Spain, Germany, United States, Italy, France
EpiCast Report: Cushing's Syndrome - Epidemiology Forecast to 2023

EpiCast Report: Cushing's Syndrome - Epidemiology Forecast to 2023

  • $ 3 995
  • Industry report
  • October 2014
  • by Global Data

EpiCast Report: Cushing's Syndrome - Epidemiology Forecast to 2023 Summary Cushing's syndrome (CS) is a rare disorder caused by prolonged exposure to excess amounts of circulating free glucocorticoids, ...

  • Industries : Pathology
  • Countries : United States, World
PharmaLeaders: Global Pharmaceutical Market Benchmark Report - Retrospective and Forward-Looking Analysis of the Leading Pharmaceutical Companies

PharmaLeaders: Global Pharmaceutical Market Benchmark Report - Retrospective and Forward-Looking Analysis of the Leading Pharmaceutical Companies

  • $ 3 995
  • Industry report
  • October 2014
  • by Global Data

PharmaLeaders: Global Pharmaceutical Market Benchmark Report - Retrospective and Forward-Looking Analysis of the Leading Pharmaceutical Companies Summary The Global Pharmaceutical Market Benchmark Report ...

  • Industries : Drug and Medication
  • Countries : World
EpiCast Report: Dyslipidemia - Epidemiology Forecast to 2023

EpiCast Report: Dyslipidemia - Epidemiology Forecast to 2023

  • $ 3 995
  • Industry report
  • October 2014
  • by Global Data

EpiCast Report: Dyslipidemia - Epidemiology Forecast to 2023 Summary Dyslipidemia is a condition in which one or more of the serum lipid levels are abnormal. It is a well-established risk factor for cardiovascula ...

  • Industries : Pathology
  • Countries : Germany, Japan, China, World, United States
EpiCast Report: Allergic Conjunctivitis - Epidemiology Forecast to 2023

EpiCast Report: Allergic Conjunctivitis - Epidemiology Forecast to 2023

  • $ 3 995
  • Industry report
  • October 2014
  • by Global Data

EpiCast Report: Allergic Conjunctivitis - Epidemiology Forecast to 2023 Summary Allergic conjunctivitis is an inflammation of the eye resulting from an allergic reaction to allergy causing substances (external ...

  • Industries : Pathology
  • Countries : World, United States, Spain, Italy, France, Germany
Herceptin (HER2-Positive Breast Cancer) - Forecast and Market Analysis to 2023

Herceptin (HER2-Positive Breast Cancer) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • September 2014
  • by Global Data

Herceptin (HER2-Positive Breast Cancer) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Herceptin (HER2-Positive Breast Cancer) - Forecast ...

  • Industries : Pathology
  • Countries : World, United States, Spain, Italy, France, Germany, Japan, China, United Kingdom, Europe
Perjeta (HER2-Positive Breast Cancer) - Forecast and Market Analysis to 2023

Perjeta (HER2-Positive Breast Cancer) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • September 2014
  • by Global Data

Perjeta (HER2-Positive Breast Cancer) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Perjeta (HER2-Positive Breast Cancer) - Forecast ...

  • Industries : Pathology
  • Countries : Japan, World, Spain, Italy, France, Germany, China, United States, United Kingdom, Europe
Kadcyla (HER2-Positive Breast Cancer) - Forecast and Market Analysis to 2023

Kadcyla (HER2-Positive Breast Cancer) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • September 2014
  • by Global Data

Kadcyla (HER2-Positive Breast Cancer) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Kadcyla (HER2-Positive Breast Cancer) - Forecast ...

  • Industries : Pathology
  • Countries : Japan, World, Spain, Italy, France, Germany, China, United States, United Kingdom, Europe
Tykerb (HER2-Positive Breast Cancer) - Forecast and Market Analysis to 2023

Tykerb (HER2-Positive Breast Cancer) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • September 2014
  • by Global Data

Tykerb (HER2-Positive Breast Cancer) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Tykerb (HER2-Positive Breast Cancer) - Forecast ...

  • Industries : Pathology
  • Countries : World, Spain, Italy, France, Germany, Japan, China, Europe, United States, United Kingdom
Neratinib (HER2-Positive Breast Cancer) - Forecast and Market Analysis to 2023

Neratinib (HER2-Positive Breast Cancer) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • September 2014
  • by Global Data

Neratinib (HER2-Positive Breast Cancer) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Neratinib (HER2-Positive Breast Cancer) - Forecast ...

  • Industries : Pathology
  • Countries : Spain, Italy, France, Germany, Japan, China, World, United States, United Kingdom, Europe
EU5 Hyperbaric Oxygen Chambers Market Outlook to 2020

EU5 Hyperbaric Oxygen Chambers Market Outlook to 2020

  • $ 3 000
  • Industry report
  • October 2014
  • by Global Data

EU5 Hyperbaric Oxygen Chambers Market Outlook to 2020 Summary GlobalData's new report, "EU5 Hyperbaric Oxygen Chambers Market Outlook to 2020", provides key market data on the EU5 Hyperbaric Oxygen Chambers ...

  • Industries : Drug and Medication
  • Countries : United Kingdom, Spain, Italy, France, Germany, Europe
North America Compression Therapy Market Outlook to 2020

North America Compression Therapy Market Outlook to 2020

  • $ 3 000
  • Industry report
  • October 2014
  • by Global Data

North America Compression Therapy Market Outlook to 2020 Summary GlobalData's new report, "North America Compression Therapy Market Outlook to 2020", provides key market data on the North America Compression ...

  • Industries : Therapy
  • Countries : United States, North America, Mexico, Canada
BRIC Compression Therapy Market Outlook to 2020

BRIC Compression Therapy Market Outlook to 2020

  • $ 3 000
  • Industry report
  • October 2014
  • by Global Data

BRIC Compression Therapy Market Outlook to 2020 Summary GlobalData's new report, "BRIC Compression Therapy Market Outlook to 2020", provides key market data on the BRIC Compression Therapy market. The ...

  • Industries : Therapy
  • Countries : Brazil, Russian Federation, India, China
Asia-Pacific Compression Therapy Market Outlook to 2020

Asia-Pacific Compression Therapy Market Outlook to 2020

  • $ 3 000
  • Industry report
  • October 2014
  • by Global Data

Asia-Pacific Compression Therapy Market Outlook to 2020 Summary GlobalData's new report, "Asia-Pacific Compression Therapy Market Outlook to 2020", provides key market data on the Asia-Pacific Compression ...

  • Industries : Therapy
  • Countries : South Korea, Australia, China, India, Japan, Asia, World, Oceania
EU5 Compression Therapy Market Outlook to 2020

EU5 Compression Therapy Market Outlook to 2020

  • $ 3 000
  • Industry report
  • October 2014
  • by Global Data

EU5 Compression Therapy Market Outlook to 2020 Summary GlobalData's new report, "EU5 Compression Therapy Market Outlook to 2020", provides key market data on the EU5 Compression Therapy market. The report ...

  • Industries : Therapy
  • Countries : France, Germany, Italy, United Kingdom, Spain, Europe
Community-Acquired Bacterial Pneumonia Global Clinical Trials Review, H2, 2014

Community-Acquired Bacterial Pneumonia Global Clinical Trials Review, H2, 2014

  • $ 2 500
  • Industry report
  • November 2014
  • by Global Data

Community-Acquired Bacterial Pneumonia Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Community-Acquired Bacterial Pneumonia Global Clinical Trials Review, H2, 2014" ...

  • Industries : Drug Discovery and Development
  • Countries : World
Community-Acquired Infections Global Clinical Trials Review, H2, 2014

Community-Acquired Infections Global Clinical Trials Review, H2, 2014

  • $ 2 500
  • Industry report
  • November 2014
  • by Global Data

Community-Acquired Infections Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Community-Acquired Infections Global Clinical Trials Review, H2, 2014" provides data ...

  • Industries : Drug Discovery and Development
  • Countries : World
Complicated Intra-Abdominal Infections Global Clinical Trials Review, H2, 2014

Complicated Intra-Abdominal Infections Global Clinical Trials Review, H2, 2014

  • $ 2 500
  • Industry report
  • November 2014
  • by Global Data

Complicated Intra-Abdominal Infections Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Complicated Intra-Abdominal Infections Global Clinical Trials Review, H2, 2014" ...

  • Industries : Drug Discovery and Development
  • Countries : World

100 Companies

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Pfizer Inc.

United States

Novartis Inc.

Switzerland

GlaxoSmithKline PLC

United Kingdom

Johnson and Johnson

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.